PP-090 Asymptomatic carriers to obtain HBV-DNA efficacy and drug applications and selectthe relationship between treatment modalities

Zu-liang Han; Yu-sheng Sun; Yin-xiang Liu; Xin-qi Li; Jia-rui Wang

首页> 外文期刊>International journal of infectious diseases : >PP-090 Asymptomatic carriers to obtain HBV-DNA efficacy and drug applications and selectthe relationship between treatment modalities

【24h】

PP-090 Asymptomatic carriers to obtain HBV-DNA efficacy and drug applications and selectthe relationship between treatment modalities

机译：PP-090无症状载体，用于获得HBV-DNA功效和药物应用并选择治疗方式之间的关系

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《International journal of infectious diseases :》 |2009年第1期|共1页
作者
Zu-liang Han; Yu-sheng Sun; Yin-xiang Liu; Xin-qi Li; Jia-rui Wang;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类传染病;
关键词

相似文献

外文文献
中文文献
专利

1. PP-089 HBeAg-negative asymptomatic carriers in the drug alone and in combination with the effect of HBV-DNA relationship [J] . Zu-liang Han, Yu-sheng Sun, Xin-qi Li International journal of infectious diseases : . 2009,第Supplementa1期

机译：PP-089 HBeAg阴性无症状携带者单独存在，并与HBV-DNA关系有关
2. PP-088 Asymptomatic carriers and chronic hepatitis B antiviral therapy and efficacy with non-specific immune activation of the relationship between the drug applications [J] . Zu-liang Han, Yu-sheng Sun, Xin-qi Li International journal of infectious diseases : . 2009,第Supplementa1期

机译：PP-088无症状携带者与慢性乙型肝炎抗病毒治疗及疗效与非特异性免疫激活药物应用之间的关系
3. Development and evaluation of colloidal modified nanolipid carrier: Application to topical delivery of tacrolimus, part II-In vivo assessment, drug targeting, efficacy, and safety in treatment for atopic dermatitis [J] . PopleP.V., SinghK.K. European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fuer Pharmazeutische Verfahrenstechnik e.V . 2013,第1期

机译：胶体修饰的纳米脂质载体的开发和评估：他克莫司局部给药的应用，第二部分-体内评估，靶向药物，疗效和特应性皮炎的安全性
4. Engineering a novel cellular trafficking pathway for transferrin to improve its drug carrier efficacy [C] . Kamei Daniel T. Nano/Micro Engineered and Molecular Systems, 2009. NEMS 2009 . 2009

机译：为转铁蛋白设计新的细胞运输途径，以改善其药物载体的功效
5. The predictive relationship of drug-abstinence self-efficacy, health locus of control, drug use severity, and HIV illness severity on readiness to change drug use among out-of-treatment HIV+ drug users. [D] . Hall, Joan. 2007

机译：戒毒HIV +吸毒者中戒毒自我效能，控制的健康场所，药物使用严重性和HIV疾病严重性与准备改变药物使用之间的预测关系。
6. Hyaluronan-lysine cisplatin drug carrier for treatment of localized cancers: pharmacokinetics tolerability and efficacy in rodents and canines [O] . Ti Zhang, Shuang Cai, Chad Groer, -1

机译：透明质酸赖氨酸顺铂药物载体用于治疗局部癌症：在鼠类和犬类中的药代动力学耐受性和功效
7. PP-090 Asymptomatic carriers to obtain HBV-DNA efficacy and drug applications and selectthe relationship between treatment modalities [O] . Han Zu-liang, Sun Yu-sheng, Liu Yin-xiang, 2009

机译：PP-090无症状载体，用于获得HBV-DNA功效和药物应用并选择治疗方式之间的关系
8. Technical Modification Within the Healthcare Industry: Improving Both the Efficacy of the National Drug Code Carrier and the Accessibility of Electronic Health Records to Reduce Adverse Drug Events. [R] . Dixon, J. J., McLean, A. S. 2013

机译：医疗行业内的技术改造：提高国家药品代码载体的效力和电子健康记录的可及性，以减少不良药物事件。

PP-090 Asymptomatic carriers to obtain HBV-DNA efficacy and drug applications and selectthe relationship between treatment modalities

著录项

相似文献

相关主题

期刊订阅